Atrás
Precio Guangzhou Innogen Pharmaceutical Group Co., Ltd (02591.HK)
Gráfico del Precio de Acciones 02591.HK
INNOGEN-B (02591.HK)
Guangzhou Innogen Pharmaceutical Group Co., Ltd
HK$27.66
0.94%
$0.26
Mercado cerrado: Feb 16, 12:00:00 HKT
Estadísticas clave
Cierre Anterior
$27.6
Precio de apertura
$27.4
Rango del día
$27.04 - $27.7
Rango de 52 semanas
$25.5 - $74
Volumen
19.6K
Volumen promedio
1.0M
EPS (TTM)
-0.55
Rendimiento de dividendos
--
Cap. de mercado
$11.6B
¿Qué es INNOGEN-B?
Guangzhou Innogen Pharmaceutical Group Co., Ltd. engages in the production and distribution of pharmaceutical products. The company is headquartered in Guangzhou, Guangdong and currently employs 105 full-time employees. The company went IPO on 2025-08-15. The firm is primarily engaged in the commercialization of innovative, humanized, long-acting glucagon-like peptide-1 (GLP-1) receptor agonist. The firm is dedicated to developing therapies for diabetes and other metabolic diseases. The Company’s core product, Efsubaglutide Alfa (brand name: Diabegone), is used for the treatment of type 2 diabetes (T2D). The Company’s primary pipeline drug candidates include YN014, YN401, YN209, YN203, and YN202. The firm principally conducts its businesses in the domestic market.
Características
© 2026 Finture Development Limited. Todos los derechos reservados.